Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NFATc

S A Wolfe1, P Zhou, V Dötsch

  • 1Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA.

Nature
|January 9, 1997
PubMed

Insights

Researchers identified the NFATc DNA-binding domain (NFATc-DBD), crucial for immune response regulation. This discovery aids in developing new drugs targeting NFAT directly, potentially reducing immunosuppressive therapy side effects.

Area of Science:

  • Molecular Biology
  • Immunology
  • Structural Biology

Background:

  • Nuclear factor of activated T-cells (NFAT) proteins regulate immune responses.
  • Current immunosuppressants like FK506 and cyclosporin A (CsA) target NFAT signaling but cause toxic side effects.
  • Direct NFAT antagonists could offer safer alternatives.

Purpose of the Study:

  • To identify and characterize the DNA-binding domain of NFATc (NFATc-DBD).
  • To determine the solution structure of NFATc-DBD for structure-based drug design.
  • To understand NFAT's DNA binding and transcriptional activation mechanisms.

Main Methods:

  • Protein expression and purification of NFATc-DBD.
  • Nuclear Magnetic Resonance (NMR) spectroscopy for structure determination.
  • Comparative structural analysis with NF-kappaB p50.

Main Results:

  • The 20 kDa NFATc-DNA binding domain (NFATc-DBD) was identified as necessary and sufficient for DNA binding and transcriptional activation.
  • The solution structure of NFATc-DBD was determined.
  • NFATc-DBD employs a distinct DNA recognition strategy compared to NF-kappaB p50.
  • A model for the cooperative complex of NFAT and AP-1 on the interleukin-2 enhancer was proposed.

Conclusions:

  • The NFATc-DBD structure provides a basis for designing novel NFAT-targeted immunosuppressants.
  • Understanding NFAT's DNA binding mechanism is key to developing safer therapeutic strategies.
  • This work facilitates the development of antagonists with potentially reduced toxicity compared to current drugs.

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Nucleoid01:24

Nucleoid

The nucleoid represents a structurally and functionally distinct region within prokaryotic cells, where the cell's DNA and associated proteins are housed. Unlike eukaryotic cells, prokaryotes lack a membrane-bound nucleus, and the nucleoid facilitates the organization and accessibility of the genetic material within this constraint. The DNA in most bacteria and archaea exists as a single, circular, double-stranded molecule that is highly compacted through supercoiling and interactions with...